Should patients undergoing surgery take Aspirin?

To resolve the issue, Canadian surgeons say they would welcome a randomized controlled trial, and allow their patients to participate in it, said Dr. Rajesh Hiralal, who led the survey and presented its results today in Vancouver at the annual meeting of the Canadian Society of Cardiac Surgeons.

The findings are significant because non-cardiac surgery, such as hip replacements and cancer surgery, makes up 95 per cent of all surgery performed today and the numbers are growing. Cardiac surgery accounts for less than five per cent.

Close to 100 million adults world-wide--and half a million Canadians--undergo major non-cardiac surgery annually. Globally, upwards of one million of these patients go on to suffer a non-fatal heart attack, non-fatal cardiac arrest or death as a result of their surgery, said Dr. Hiralal.

"One of the great tragedies is that despite the advances we've had in surgeries and anaesthesia, we have people potentially getting cures of their cancer, or a new hip, with a new lease on life, who either may die around the time of surgery because of heart complications or they may have a non-fatal event which can actually take their life three to six months later," said Dr. P.J. Devereaux, one of 15 McMaster researchers who undertook the survey.

As a blood thinner, Aspirin provides potential protection from the development of blood clots following surgery. However, most studies on its use have been conducted on patients undergoing cardiac surgery. There has never been a large trial to address whether or not Aspirin is effective for non-cardiac surgery.

To get a reading on current practices around the use of Aspirin, McMaster researchers sent a questionnaire to 1,850 Canadian surgeons who are members of the Canadian Orthopedic Association, the Canadian Association of General Surgeons and the Canadian Society of Vascular Surgery. More than 900 responded.

They found "marked variability" in practice between the three surgical specialties.

"Among surgeons in general there is a lot of practice variation in how they are managing Aspirin at the time of surgery," said Dr. Devereaux. "They are doing very different things and there is no consistency. They are uncertain if there is a real benefit and if that benefit outweighs the risk, even if there is, in fact, a risk."

The McMaster researchers represented a multi-disciplinary group of specialists in cardiology, anaesthesia and surgery as well as intensivists and internists.

Source: McMaster University

System constraints forcing Canadian physicians to become medical brokers in prioritizing
Hip/knee replacement candidates
Health-care system constraints combined with a lack of a uniform referral process are leaving Ontario physicians brokering which patients are in greatest need of hip and knee replacement, a study led by a St. Michael's Hospital researcher funded by the Canadian Institutes of Health Research has revealed. The variability in this process means not everyone who needs this surgery will actually get surgery.
Aprotinin associated with increased risk of death
Aprotinin is associated with a 50 per cent increase in the relative risk of death, according to a major Canadian clinical trial comparing three drugs routinely used to prevent blood loss during heart surgery. The trial, published in the New England Journal of Medicine, shows that approximately six per cent of patients who received aprotinin died within 30 days of surgery compared to four per cent of patients who received tranexamic acid or aminocaproic acid.
Gender bias may affect care of people with osteoarthritis, study finds
Unconscious prejudices among doctors may explain why women complaining of knee pain are less likely than men to be recommended for total knee replacement surgery, a study in today's issue of the Canadian Medical Association Journal suggests.
Surgery by satellite -- New possibilities at medicine's cutting edge
Robotic surgery may be coming to your town. Robots that perform surgery can be driven by surgeons who no longer stand by the patient, but direct the operation from a computer console. In most cases the surgeon is seated at a console within the theatre, only a few metres away from the patient. Now a team of surgeons and scientists have shown that the surgeon and robot can be linked via a 4,000 mile Internet connection, or by satellite, reported in the journal The International Journal of Medical Robotics and Computer Assisted Surgery.
The bionic arm is the future of prosthetics, and it's here today
(PhysOrg.com) -- Alberta Health Services' Glenrose Rehabilitation Hospital is pioneering a major advancement in upper-limb amputation surgery and rehabilitation with the Canadian debut of the Targeted Muscle Reinnervation procedure, or bionic arm.
Unclear how much pounding new hips, knees can take
(AP) -- One in 75 patients who gets a knee or hip replaced must get it replaced again within three years, new research finds, although the studies underscore a question: Just how much pounding can a new joint take if you want it to last?
Combined minimally invasive procedures offer new option for lumbar degenerative scoliosis
Surgeons at Cedars-Sinai Medical Center's Institute for Spinal Disorders have combined three innovative minimally invasive spine surgery procedures to treat spinal curvature in adults, a common consequence of aging. An article in the October issue of the Journal of Spinal Disorders and Techniques is believed to be the first to document the use of these procedures in combination to correct this condition, known as adult lumbar degenerative scoliosis.
Nanodiamond drug device could transform cancer treatment
A Northwestern University research team has developed a promising nanomaterial-based biomedical device that could be used to deliver chemotherapy drugs locally to sites where cancerous tumors have been surgically removed.

Should patients undergoing surgery take Aspirin?

Related stories:

News discussion: